Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zofin in COVID-19 Long Haulers
NCT05228899Phase 2Completed
- Sponsor
- Organicell Regenerative Medicine
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of zofin in post acute COVID-19 syndrome, sponsored by Organicell Regenerative Medicine. Started Apr 2022; status: completed.
02
Drugs
zofin
03
Conditions
post acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT05228899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05228899.